FewerJobs.
Employers

Employer profile

Jade Biosciences Inc

5 open roles indexed with location, benefit, and apply-link signals where available.

ATS: greenhouse

Open roles

Showing the most recent indexed roles for this employer.

Search all matching jobs

  • Senior/Executive Director, Quality Management System

    Boston; Chicago; San Francisco; Seattle

    unspecified $250K-$280K

    Senior/Executive Director, Quality Management System Boston; Chicago; San Francisco; Seattle About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview The Senior/Executive Director, Quality Management System (QMS) will be responsible for driving and delivering the activities necessary to develop, implement, and continuously improve a phase appropriate GxP QMS. This role will be directly involved with both strategy development and day-to-day tactical execution related to QMS processes such as Document Management, Training Management, Change Control, Management Review (MR), Annual Product Quality Review (APQR), Deviation, CAPA, Risk Management, and GxP Computer System Assurance. The Sr./Exec. Director will be responsible for the maintenance of both paper-based and electronic processes and lead quality initiatives to support the pace and growth of the organization. This role will maintain and ensure effectiveness of quality programs and documentation to assure compliance and inspection readiness with all applicable quality requirements and regulatory standards. The ideal candidate brings hands-on expertise in creating and maintaining a GxP

  • Director, GMP Quality Assurance

    Boston; Chicago; San Francisco; Seattle

    unspecified $210K-$235K

    Director, GMP Quality Assurance Boston; Chicago; San Francisco; Seattle About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview The Director, GMP Quality Assurance (QA) provides QA support across Jade's product pipeline across various stages of development. This role serves as a key partner to CMC and cross-functional teams, offering QA expertise, guidance and risk-based input to support development and product quality strategies. The role provides QA oversight of contract manufacturers (CMOs) and service providers supporting cell bank, drug substance (DS), drug product (DP), finished drug product (FDP) packaging and labeling, and product distribution, ensuring alignment with GMP requirements and Jade quality standards. Additionally, the position coordinates day-to-day GMP quality activities for outsourced manufacturing, including the intake, routing, tracking, and timely archival of quality records such as batch disposition, deviations, CAPAs, change controls, expiry/retest extensions, and product complaints. The Director collaborates with internal and external stakeholders to support timely, compliant documentation and batch release decisions. Additionally, the

  • Associate Director, Clinical Site Budgets & Payments

    Boston; Chicago; San Francisco; Seattle

    unspecified $170K-$190K

    Associate Director, Clinical Site Budgets & Payments Boston; Chicago; San Francisco; Seattle About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview The Associate Director, Clinical Site Budgets & Payments will architect and lead the company's global approach to clinical trial site budgeting, investigator grant strategy, transparency compliance, and site/vendor payment governance across our clinical trial portfolio. This leader will define Jade's global investigator grant philosophy, including structured opening offer and negotiation parameters that ensure speed, fairness, and alignment with global FMV benchmarks. They will establish standards for invoiceables, conditional procedures, pass‑through costs, and country‑specific budgeting norms that apply across all Jade clinical studies. This role oversees a full‑service CRO partner responsible for operational execution of budgets, payments, reconciliation, and study financial controls. It also builds and maintains global site budget forecasts, ensures just‑in‑time CRO funding, and supports accruals, reconciliation, and inspection‑readiness. The successful candidate must be equally fluent in clinical trial protocols and financial statements, highly

  • Executive Director, Clinical Quality Assurance

    Boston; San Francisco; Seattle

    unspecified $265K-$300K

    Executive Director, Clinical Quality Assurance Boston; San Francisco; Seattle About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview The Executive Director, Clinical Quality Assurance (CQA) will be responsible for all aspects of Quality Assurance focused on Good Clinical Practice (GCP), Good Pharmacovigilance Practices (GPvP) and Good Laboratory Practices (GLP) activities to ensure quality assurance and compliance of Jade sponsored clinical trials with applicable regulations, ICH guidelines, OECD Principles of GLP, Jade procedures and policies, and current industry standards and practices. The Executive Director, Clinical Quality Assurance will perform day-to-day clinical quality operations and compliance activities to support the success of our clinical programs in addition to being a strategic partner to Clinical Development and Operations. This role will maintain and ensure effectiveness of quality programs and documentation to assure compliance and inspection readiness with all applicable quality requirements and regulatory standards. The ideal candidate brings hands-on expertise in GCP, GPvP and GLP QA operations, a proactive

  • Senior Director, Clinical Operations

    Boston; Chicago; San Francisco; Seattle

    unspecified $255K-$280K

    Senior Director, Clinical Operations Boston; Chicago; San Francisco; Seattle About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn . Role Overview The Senior Director, Clinical Operations is responsible for directing the strategy, management, and oversight of clinical program(s) and functional activities as assigned. Key Responsibilities - Acts as Clinical Operations program lead for assigned program(s) - R epresent Clinical Operations at the Clinical Development Team and /or Global Program Team - Develops and executes program operational strategy - Partners closely and effectively with other functions and functional heads to drive program forward - Provides strategic and technical recommendations to senior leadership - Directs the selection of CROs and other vendors ( IxRS , Central Lab, ancillary/tech vendors) - Acts as an escalation point for CRO/vendor issues - Directs development of vendor Scopes of Work (SOW), scope changes, budgets, and vendor payments - Partners with CRO and other vendors to deliver on study execution - Creates and tracks clinical program